1. Home
  2. Live Updates
  3. Venous thromboembolism

Live Breaking News & Updates on Venous thromboembolism

Stay informed with the latest breaking news from Venous thromboembolism on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Venous thromboembolism and stay connected to the pulse of your community

Anticoagulants Market size to record USD 18.09 billion growth from 2023-2027, Advent of anticoagulant antidotes is one of the key market trends, Technavio

/PRNewswire/ -- The global anticoagulants market size is estimated to grow by USD 18.09 billion from 2023 to 2027, according to Technavio. The market is...

United-states , United-kingdom , India , Mexico , China , America , Jesse-maida , Technavio-research , Trends-fueling-growth , Middle-east , North-america , Anticoagulants-market

Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma

1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score < 7 and not receiving anticoagulation. 2. There was no significant difference between the control and intervention phases regarding secondary outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: Venous thromboembolism (VTE) is a well-recognized potential complication resulting from orthopedic trauma and

Belgium , France , Rating-level , Thrombosis-risk-prediction , Cast-immobilization , Low-molecular-weight-heparin , Between-jun , Ral-anticoagulation , Anticoagulation , Lower-limb-injury , Lower-limb-trauma

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , Cambridge , Cambridgeshire , United-kingdom , Massachusetts , Americans , Glennm-chertow , Lori-hartwell , Johnp-butler , Clin-nephrol , Division-of-nephrology-at-stanford-university

Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients

/PRNewswire/ -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...

Melbourne , Victoria , Australia , Japan , Switzerland , United-states , Thomas-hutter , Glennm-chertow , Clin-nephrol , Steering-committee , Drug-administration , Fresenius-medical-care

Pulmonary Embolism and Deep Vein Thrombosis / Venous Thromboembolism

Deep vein thrombosis (DVT) is a condition where blood clots develop usually in the deep veins of the legs. Pulmonary embolism (PE) occurs when these clots break away and block the pulmonary artery.

United-states , Venous-thromboembolism ,

Global Venous Thromboembolism Treatment Market To Reach $4.40 Billion By 2030, As Demand For Minimally Invasive Procedures Grows

Global Venous Thromboembolism Treatment Market To Reach $4.40 Billion By 2030, As Demand For Minimally Invasive Procedures Grows
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , Ireland , Dublin , France , Boston , Massachusetts , United-states , Germany , Japan , India , Canada , Spain

Two-thirds ED Visits for Low-Risk PE Admitted Unnecessarily

Nearly two thirds of ED visits by patients with acute pulmonary embolism resulted in unnecessary hospitalization, suggested a new study.

United-states , Boston , Massachusetts , Nathanw-watson , Harvard-medical-school , Emergency-department , National-hospital-ambulatory-medical-care , National-hospital-ambulatory-medical-care-survey , Pulmonary-embolism-severity-index , Pulmonary-embolism-pe-embolus , Thromboembolism

MACE, VTE Risks Not Increased With JAK inhibitors: Study

In studies with an average follow-up of 16 weeks, there was no significant increase in MACE or VTE rates in people with dermatoses treated with JAK-STAT inhibitors.

Ireland , Washington , United-states , Randwick , New-south-wales , Australia , Adam-friedman , Eli-lily , Drug-administration , University-of-new-south-wales , George-washington-university , Pfizer

Study Identifies Critical Risk Factors for VTE After Pulmonary Resection

A recent analysis found risk factors linked to an embolism after VTE included Black race, interstitial fibrosis, advanced-stage disease, and increased operative duration.

United-states , Americans , Andreal-axtell , Centers-for-disease , Public-health , University-of-wisconsin-school-medicine , Breakthrough-research-identifies-predictors-of-venous-thromboembolism , Society-of-thoracic-surgeons , University-of-wisconsin-andreal-axtell , Thoracic-surgeons , Annual-meeting

Limerick hospital's 'regret' over death of Eve Cleary (21) who was told to go home and rest

The family of Eve Cleary has settled a High Court action over the death of the 21-year-old hours after she was discharged from University Hospital Limerick (UHL) and told to go home and rest.

Justice-paul-coffey , Melanie-sheehan-cleary , Barry-cleary , Justice-coffey , Ul-hospital-group , Ul-hospitals-group , High-court , Co-limerick , Eve-cleary , Venous-thromboembolism ,